STAT

Opinion: Taking a grassroots approach to fighting the opioid epidemic

Doctors and hospitals don't need to wait for large-scale state federal programs to fight inappropriate opioid use.

For many physicians, developing an ongoing relationship with patients is a rewarding part of the job. That’s not the case for emergency physicians like me — we’d rather not see the same patients over and over again, especially those with substance use disorders, who are some of the highest users of emergency care.

I can vividly recall the first time that the opioid epidemic became real to me. One day in September 2011, I was working in the emergency department when a 23-year-old patient arrived in cardiac arrest, apparently caused by an opioid overdose. My team did what it could, but we could not resuscitate the patient. When I talked with his family, they told me that multiple care providers had written him prescriptions for pain medications.

That got me wondering if this tragedy could have been prevented if his providers had been able to easily and securely coordinate

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks